(NASDAQ: FLGC) Flora Growth's forecast annual revenue growth rate of 8.73% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 13.54%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.23%.
Flora Growth's revenue in 2024 is $76,071,000.On average, 2 Wall Street analysts forecast FLGC's revenue for 2024 to be $743,180,710, with the lowest FLGC revenue forecast at $714,743,704, and the highest FLGC revenue forecast at $771,617,716.
In 2025, FLGC is forecast to generate $775,391,347 in revenue, with the lowest revenue forecast at $775,391,347 and the highest revenue forecast at $775,391,347.